Clinical Trials for: promethazine hydrochloride
Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine
Status: Recruiting Condition: Drug Metabolism, Poor, CYP2D6-RELATED
Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine
Status: Completed Condition: Sleep
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
Status: Terminated Condition: Nausea; Vomiting; Unspecified Childhood Solid Tumor, Protocol Specific
Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis
Status: Completed Condition: Aphthous Stomatitis
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
Status: Completed Condition: Focus of Study: Absorption of the Three Components in the Topical ABH Gel in Healthy Volunteers, and Determine if There Are Any Adverse Effects.
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Patients With Nausea
Status: Active, not recruiting Condition: Nausea and Vomiting
A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery
Status: Completed Condition: Surgery; Pain
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
Status: Completed Condition: Nasal Congestion
Diphenhydramine for Acute Migraine
Status: Recruiting Condition: Migraine
Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination
Status: Completed Condition: Therapeutic Equivalence
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
Bristol Myers Squibb
|TABLET; ORAL||083176||Approved Prior to Jan 1, 1982||DISCN||No||<disabled>||<disabled>|
Zydus Pharms Usa
|TABLET; ORAL||040596||Nov 18, 2005||RX||No||<disabled>||<disabled>|
|TABLET; ORAL||085664||Approved Prior to Jan 1, 1982||DISCN||No||<disabled>||<disabled>|
|TABLET; ORAL||083711||Approved Prior to Jan 1, 1982||RX||No||<disabled>||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639